These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26834024)

  • 1. Cost-Effectiveness of Comprehensive, Integrated Care for First Episode Psychosis in the NIMH RAISE Early Treatment Program.
    Rosenheck R; Leslie D; Sint K; Lin H; Robinson DG; Schooler NR; Mueser KT; Penn DL; Addington J; Brunette MF; Correll CU; Estroff SE; Marcy P; Robinson J; Severe J; Rupp A; Schoenbaum M; Kane JM
    Schizophr Bull; 2016 Jul; 42(4):896-906. PubMed ID: 26834024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program.
    Kane JM; Robinson DG; Schooler NR; Mueser KT; Penn DL; Rosenheck RA; Addington J; Brunette MF; Correll CU; Estroff SE; Marcy P; Robinson J; Meyer-Kalos PS; Gottlieb JD; Glynn SM; Lynde DW; Pipes R; Kurian BT; Miller AL; Azrin ST; Goldstein AB; Severe JB; Lin H; Sint KJ; John M; Heinssen RK
    Am J Psychiatry; 2016 Apr; 173(4):362-72. PubMed ID: 26481174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of early intervention in first-episode psychosis: economic evaluation of a randomised controlled trial (the OPUS study).
    Hastrup LH; Kronborg C; Bertelsen M; Jeppesen P; Jorgensen P; Petersen L; Thorup A; Simonsen E; Nordentoft M
    Br J Psychiatry; 2013 Jan; 202(1):35-41. PubMed ID: 23174515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised controlled trial to improve health and reduce substance use in established psychosis (IMPaCT): cost-effectiveness of integrated psychosocial health promotion.
    Heslin M; Patel A; Stahl D; Gardner-Sood P; Mushore M; Smith S; Greenwood K; Onagbesan O; O'Brien C; Fung C; Ohlsen R; Hopkins D; Lowe P; Arbuthnot M; Mutatsa S; Todd G; Kolliakou A; Lally J; Stubbs B; Ismail K; David A; Murray R; Atakan Z; Gaughran F
    BMC Psychiatry; 2017 Dec; 17(1):407. PubMed ID: 29273021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Better care for less money: cost-effectiveness of integrated care in multi-episode patients with severe psychosis.
    Karow A; Brettschneider C; Helmut König H; Correll CU; Schöttle D; Lüdecke D; Rohenkohl A; Ruppelt F; Kraft V; Gallinat J; Lambert M
    Acta Psychiatr Scand; 2020 Mar; 141(3):221-230. PubMed ID: 31814102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Economic Evaluation of Coordinated Specialty Care (CSC) Services for First-Episode Psychosis in the U.S. Public Sector.
    Murphy SM; Kucukgoncu S; Bao Y; Li F; Tek C; Breitborde NJK; Guloksuz S; Phutane VH; Ozkan B; Pollard JM; Cahill JD; Woods SW; Cole RA; Schoenbaum M; Srihari VH
    J Ment Health Policy Econ; 2018 Sep; 21(3):123-130. PubMed ID: 30530872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia.
    Rosenheck RA; Leslie DL; Sint KJ; Lin H; Li Y; McEvoy JP; Byerly MJ; Hamer RM; Swartz MS; Stroup TS
    Psychiatr Serv; 2016 Oct; 67(10):1124-1130. PubMed ID: 27247177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive Behavioural Therapy for Psychosis: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2018; 18(5):1-141. PubMed ID: 30443277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of an early intervention service for people with psychosis.
    McCrone P; Craig TK; Power P; Garety PA
    Br J Psychiatry; 2010 May; 196(5):377-82. PubMed ID: 20435964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes During and After Early Intervention Services for First-Episode Psychosis: Results Over 5 Years From the RAISE-ETP Site-Randomized Trial.
    Robinson DG; Schooler NR; Marcy P; Gibbons RD; Hendricks Brown C; John M; Mueser KT; Penn DL; Rosenheck RA; Addington J; Brunette MF; Correll CU; Estroff SE; Mayer-Kalos PS; Gottlieb JD; Glynn SM; Lynde DW; Gingerich S; Pipes R; Miller AL; Severe JB; Kane JM
    Schizophr Bull; 2022 Sep; 48(5):1021-1031. PubMed ID: 35689478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NAVIGATE Program for First-Episode Psychosis: Rationale, Overview, and Description of Psychosocial Components.
    Mueser KT; Penn DL; Addington J; Brunette MF; Gingerich S; Glynn SM; Lynde DW; Gottlieb JD; Meyer-Kalos P; McGurk SR; Cather C; Saade S; Robinson DG; Schooler NR; Rosenheck RA; Kane JM
    Psychiatr Serv; 2015 Jul; 66(7):680-90. PubMed ID: 25772766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Early Psychosis Intervention Center (EPICENTER): development and six-month outcomes of an American first-episode psychosis clinical service.
    Breitborde NJ; Bell EK; Dawley D; Woolverton C; Ceaser A; Waters AC; Dawson SC; Bismark AW; Polsinelli AJ; Bartolomeo L; Simmons J; Bernstein B; Harrison-Monroe P
    BMC Psychiatry; 2015 Oct; 15():266. PubMed ID: 26511605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is early intervention in psychosis cost-effective over the long term?
    Mihalopoulos C; Harris M; Henry L; Harrigan S; McGorry P
    Schizophr Bull; 2009 Sep; 35(5):909-18. PubMed ID: 19509308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of 12-month therapeutic assertive community treatment as part of integrated care versus standard care in patients with schizophrenia treated with quetiapine immediate release (ACCESS trial).
    Karow A; Reimer J; König HH; Heider D; Bock T; Huber C; Schöttle D; Meister K; Rietschel L; Ohm G; Schulz H; Naber D; Schimmelmann BG; Lambert M
    J Clin Psychiatry; 2012 Mar; 73(3):e402-8. PubMed ID: 22490266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceived Autonomy Support in the NIMH RAISE Early Treatment Program.
    Browne J; Penn DL; Bauer DJ; Meyer-Kalos P; Mueser KT; Robinson DG; Addington J; Schooler NR; Glynn SM; Gingerich S; Marcy P; Kane JM
    Psychiatr Serv; 2017 Sep; 68(9):916-922. PubMed ID: 28566027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RAISE early treatment program for first-episode psychosis: background, rationale, and study design.
    Kane JM; Schooler NR; Marcy P; Correll CU; Brunette MF; Mueser KT; Rosenheck RA; Addington J; Estroff SE; Robinson J; Penn DL; Robinson DG
    J Clin Psychiatry; 2015 Mar; 76(3):240-6. PubMed ID: 25830446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive early intervention for patients with first-episode psychosis in Japan (J-CAP): study protocol for a randomised controlled trial.
    Koike S; Nishida A; Yamasaki S; Ichihashi K; Maegawa S; Natsubori T; Harima H; Kasai K; Fujita I; Harada M; Okazaki Y
    Trials; 2011 Jun; 12():156. PubMed ID: 21689393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE): randomised controlled trial.
    Holt RIG; Gossage-Worrall R; Hind D; Bradburn MJ; McCrone P; Morris T; Edwardson C; Barnard K; Carey ME; Davies MJ; Dickens CM; Doherty Y; Etherington A; French P; Gaughran F; Greenwood KE; Kalidindi S; Khunti K; Laugharne R; Pendlebury J; Rathod S; Saxon D; Shiers D; Siddiqi N; Swaby EA; Waller G; Wright S
    Br J Psychiatry; 2019 Feb; 214(2):63-73. PubMed ID: 30251622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
    Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
    Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effectiveness of a Patient-Centred Assessment with a Solution-Focused Approach (DIALOG+) for Patients with Psychosis: A Pragmatic Cluster-Randomised Controlled Trial in Community Care.
    Priebe S; Kelley L; Omer S; Golden E; Walsh S; Khanom H; Kingdon D; Rutterford C; McCrone P; McCabe R
    Psychother Psychosom; 2015; 84(5):304-13. PubMed ID: 26278784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.